Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference

PONTE VEDRA, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, announces it will highlight new product innovations at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference in Austin, Texas from February 24-27.

Several new technologies will be featured at Treace Medical’s exhibit (booth #322) at the ACFAS conference:  

• Lapiplasty® 3-n-1™ Guide: The 3-n-1™ Guide is an advanced instrument specifically developed as part of efforts to continuously advance the speed and reproducibility of the Lapiplasty® 3D Bunion Correction™ procedure. The 3-n-1™ Guide combines multiple devices into a single precision instrument and is designed to reduce surgical time and increase the efficiency of the deformity realignment and joint preparation steps of the Lapiplasty® procedure.
• Expansion of the Adductoplasty™ System: The full commercial rollout of the Adductoplasty™ Midfoot Correction System adds several specialized instruments designed to improve the efficiency and expand the clinical applications of the system. The expanded Adductoplasty™ System now provides an integrated solution of specifically-designed instrumentation and implants for treating a variety of midfoot pathologies, including arthritis of the lesser tarsometatarsal joints and metatarsus adductus (MTA), a midfoot deformity that occurs in approximately 30% of bunion patients¹ and can lead to increased chance of bunion recurrence if the MTA deformity is not addressed concomitantly with the bunion correction procedure.^2,3  
• Lapiplasty® S4A Anatomic Plating System: The S4A System represents the next-generation in Lapiplasty® titanium plate fixation technology, providing foot and ankle surgeons with an additional fixation option for the Lapiplasty® 3D Bunion Correction™ procedure. Based on anatomical studies of the first tarsometatarsal joint, the S4A anatomic plates feature an advanced three-dimensional contour designed to better accommodate certain anatomic variabilities of the medial cuneiform bone.
• SpeedRelease™ and TriTome™ Release Instruments: These new single-use, specialized cutting instruments are designed to provide a more reliable and complete surgical release of key soft tissue structures commonly addressed during the Lapiplasty® and Adductoplasty™ procedures.

John T. Treace, CEO, Founder and Board Member of Treace, said “As the industry’s only company solely-focused on bunion correction, we are excited to preview our latest R&D innovations to surgeons attending the 2022 ACFAS conference. These new technologies demonstrate Treace’s commitment to rapid innovation with a focus on continually improving both the surgeon’s experience with our products and the clinical outcomes of their patients.”

This article is based on a press release from Treace Medical Concepts, Inc.